|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.67 INR | -0.67% |
|
-2.07% | -11.91% |
| Market Cap | 865M 8.98M 7.85M 7.24M 6.68M 12.59M 12.86M 86.59M 34.06M 424M 33.74M 33M 1.46B | P/E 2024 |
-214x | P/E 2025 | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 992M 10.3M 9M 8.31M 7.66M 14.44M 14.76M 99.32M 39.06M 486M 38.7M 37.85M 1.67B | EV / Sales 2024 |
1.91x | EV / Sales 2025 | 1.16x |
| Free-Float |
89.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.67% | ||
| 1 week | -2.07% | ||
| Current month | -1.00% | ||
| 3 months | -10.24% | ||
| 6 months | -5.02% | ||
| Current year | -11.91% |
| 1 week | 23 | 24.75 | |
| 1 month | 22.5 | 24.95 | |
| Current year | 15.2 | 29.9 | |
| 1 year | 15.2 | 52.5 | |
| 3 years | 15.2 | 151.45 | |
| 5 years | 15.2 | 151.45 | |
| 10 years | 2.58 | 216.04 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2017-05-03 | |
| Director of Finance/CFO | - | 2021-05-19 | |
Aman Purohit
CMP | Compliance Officer | - | 2026-03-24 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | 2017-05-03 | |
| Director/Board Member | 54 | - | |
| Director/Board Member | 44 | 2017-05-03 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.67% | -2.07% | -51.70% | -77.29% | 13.57M | ||
| +0.01% | +4.40% | +18.54% | +104.90% | 98.51B | ||
| -0.09% | -3.09% | +43.22% | +145.22% | 53.52B | ||
| -0.34% | +3.90% | +4.27% | +266.25% | 23.53B | ||
| -2.52% | +2.98% | -12.49% | -21.65% | 8.25B | ||
| -5.82% | +2.45% | -32.81% | -32.05% | 7.79B | ||
| -1.35% | +5.02% | -6.54% | -27.10% | 6.99B | ||
| +2.44% | +0.89% | +26.58% | +30.99% | 6.31B | ||
| +0.79% | +2.77% | -0.39% | +25.12% | 5.51B | ||
| -2.29% | +2.00% | -4.49% | -6.59% | 3.76B | ||
| Average | -0.98% | +1.87% | -1.58% | +40.78% | 21.42B | |
| Weighted average by Cap. | -0.36% | +2.37% | +18.60% | +112.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.41B 25.06M 21.9M 20.21M 18.62M 35.1M 35.88M 242M 94.99M 1.18B 94.1M 92.03M 4.07B | 2.93B 30.38M 26.55M 24.5M 22.58M 42.56M 43.51M 293M 115M 1.43B 114M 112M 4.93B |
| Net income | -23.87M -248K -217K -200K -184K -347K -355K -2.39M -940K -11.69M -931K -910K -40.24M | 251M 2.6M 2.28M 2.1M 1.94M 3.65M 3.73M 25.09M 9.87M 123M 9.78M 9.56M 423M |
| Net Debt | -432M -4.48M -3.92M -3.61M -3.33M -6.28M -6.42M -43.21M -16.99M -211M -16.83M -16.46M -728M | 127M 1.32M 1.15M 1.07M 982K 1.85M 1.89M 12.73M 5.01M 62.31M 4.96M 4.85M 214M |
Employees
600
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | ₹23.67 | -0.67% | 49,128 |
| 26-07-16 | ₹23.83 | -1.12% | 28,502 |
| 26-07-15 | ₹24.10 | -0.12% | 9,948 |
| 26-07-14 | ₹24.13 | +0.37% | 28,651 |
| 26-07-13 | ₹24.04 | -0.54% | 11,826 |
- Stock Market
- Stocks
- BALAXI Stock
Select your edition
All financial news and data tailored to specific country editions
















